The integration aims to ensure planning is based on real-world clinical developments, uniting internal and external insights.

The rise of AI has powered a wave of interest in digital innovation within pharma. But to have a lasting impact, AI — like any innovation in digital health — must be able to deliver value by being ...

Data quality frameworks reshape pharmaceutical quality systems in Pharma 4.0, integrating digital maturity, automation, and ...

At first glance, the Trump administration’s approach to the pharmaceutical industry appears largely deregulatory. From a data privacy and security perspective, however, the reality is more complex.

“Data-driven” is a bedrock principle of today’s pharmaceutical marketing. But how well are we keeping up with the tremendous amount of data available to us? It’s estimated that the average hospital ...

Innate Pharma (IPHA) announced the publication in Science Immunology of preclinical data demonstrating the potential of IPH6501, Innate’s proprietary NK cell engager including an IL-2v and targeting ...

As the pharmaceutical marketing landscape rapidly evolves, data analytics and artificial intelligence (AI) are driving a new era of targeted, efficient engagement, according to Stephen Onikoro, Chief ...

Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycle therapies, today announced that it presented a digital poster at the 2024 ...

Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced the presentation of preclinical data on CID-078 at the ...

Hello, and welcome to Herantis Pharma's Phase Ib Biomarker Data webinar. I am CEO, Antti Vuolanto, joined today by CSO, Henri Huttunen; and CFO, Tone Kvale. We are really excited to discuss yesterday ...

Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) is one of the best AI stocks under $50 to buy right now. On May 6, Recursion ...